University of Chicago

Medications

Repurposed drug shows promise for treating cardiac arrhythmias

Ruxolitinib, a drug that is already approved by the U.S. Food and Drug Administration (FDA) for treating certain cancers and skin conditions, is effective at inhibiting CaMKII, a protein kinase linked to cardiac arrhythmias.

Psychology & Psychiatry

Social vulnerability has direct link to suicide risk, study shows

More than 45,000 Americans died by suicide in 2020, a 30% increase over 2000, making it the 12th leading cause of death in the U.S. Studies have shown that the social and environmental factors where people live, like exposure ...

Neuroscience

Can you describe a sensation without feeling it first?

Blind or colorblind people can describe colors and use expressions like "green with envy" or "feeling blue." A hearing-impaired person can also say those same vibrant hues are "loud." But many linguists and cognitive neuroscientists ...

page 3 from 36